Lumos Diagnostics Sets Stage for US Expansion With New Contracts, Financing

Below is a great article published online here: https://www.360dx.com/about-us/our-staff/madeleine-johnson . As you need a login to access, i quickly copied and pasted the information here. Formatted some key comments etc.

@Hawk70 - Note the points about BINX and the STD market.

Key summary of some good points:

- LDX has intellectual property over the used of MxA
- Febridx is in 17 countries with a market opportunity of over $1Billion
- Product revenue quadrupled YoY
- 26 total partnerships in this most recent fiscal year for Febridx similar to Medigroup.
- Comments about universities and Febridx; fielding phone calls etc enabled an uptake in the use of Febridx
- 19 partnerships for Viradx
- Competition noted in respect of the STD tests with BINX noted again
- FFN again, 2.5Million tests conducted annually
- Confirmation around use of Lumos' other devices; Leelu for research and quality control and its desktop reader (being integrated into the FFN test)

This is probably the most informative and eye opening article I have seen published which doesn't necessarily regurgitate the announcements.